Helen S. Mayberg
||This biography of a living person needs additional citations for verification. (April 2016) (Learn how and when to remove this template message)|
Helen S. Mayberg was born in 1956 in California. She is an American neurologist. Mayberg is known in particular for her work delineating abnormal brain function in patients with major depression using functional neuroimaging. This work led to the first pilot study of deep brain stimulation (DBS), a reversible method of selective modulation of a specific brain circuit, for patients with treatment-resistant depression.
Dr. Mayberg is a board certified neurologist trained at Columbia University's Neurological Institute in New York, with fellowship training in nuclear medicine at Johns Hopkins University. She received a BA in psychobiology from UCLA and her M.D. from the University of Southern California in 1981. Dr. Mayberg is a professor of neurology and psychiatry at Emory University School of Medicine, Atlanta, GA and the Dorothy C. Fuqua Chair of Psychiatric Neuroimaging and Therapeutics. She has held previous academic appointments at Johns Hopkins University, The University of Texas Health Sciences Center in San Antonio, and the University of Toronto where she was the first Sandra Rotman Chair in neuropsychiatry.
Service and Awards
Dr. Mayberg is active in a wide variety of scientific organizations including the Society for Neuroscience, the Society of Biological Psychiatry, the American Neurological Association, the American College of Neuropsychopharmacology, and the Organization for Human Brain Mapping. She is a current member of the Dana Alliance and the Brain & Behavior Research Foundation Scientific Council, and serves on the editorial boards of the journals Neuroimage, Human Brain Mapping, Brain Stimulation, Neuroinformatics, Brain Imaging, and Behavior and Brain Structure and Function. She was elected to the Institute of Medicine of the National Academies in 2008. Dr. Mayberg is also a member of the Governing Board of the International Neuroethics Society.
Dr. Mayberg has previously served on the Clinical Neuroscience and Biological Psychopathology and the Brain Disorders and Clinical Neuroscience Study Sections at NIH and the NINDS Advisory Council. Her research program has ongoing or previous funding from the NIMH, the Canadian Institute for Health Research, NARSAD Grants, the Stanley Medical Research Institute, the Dana Foundation, and the Woodruff Fund.
Dr. Mayberg was awarded the Arnold Pfeffer Prize in Neuropsychoanalysis with her colleague Mario Liotti MD, PhD, in 2003, and the Brain & Behavior Research Foundation (formerly NARSAD) Falcone Prize in Mood Disorders Research in 2007, and was the Emil Kraeppelin Professor at the Max-Planck Institute of Psychiatry in Munich in 2008 and the Raymond Adams Lecturer at the American Neurological Association meeting in 2009 .
- Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic 
- Differences in Brain Glucose Metabolism Between Responders to CBT and Venlafaxine in a 16-Week Randomized Controlled Trial 
- Defining the Neural Circuitry of Depression: Toward a New Nosology With Therapeutic Implications 
- "Governance". International Neuroethics Society. Retrieved 28 September 2014.
- Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic : Abstract : Nature Neuroscience
- Differences in Brain Glucose Metabolism Between Responders to CBT and Venlafaxine in a 16-Week Randomized Controlled Trial - Kennedy et al. 164 (5): 778 - Am J Psychiatry
- Elsevier Article Locator
- DBS Summary
- "A Depression Switch" New York Times Magazine (April 6, 2006)